Medical expertise company RubiconMD on Thursday announced a suite of COVID-19 vaccine eConsults and resources to continue to support the primary care physicians deliver the clear, accurate communication vital in the fight against the pandemic.
RubiconMD's panel of COVID-19 vaccine experts will review the real eConsult case studies and leverage educational resources curated in partnership with CONVINCE USA Initiative at the CUNY Graduate School of Public Health and Health Policy.
Based on the survey of RubiconMD clinicians, about 50% of respondents felt that they do not have all the resources needed to make vaccine decisions to adequately address patient questions. Respondents strongly emphasized the need for digestible summaries of vaccine recommendations, clinical guidelines for patients with complex conditions, and multilingual patient-facing resources.
Following the feedback, RubiconMD encourages clinicians to reach out to their specialist experts with any vaccine questions and leverage the dashboard for continually updated curated content and CME eligible webinars.
Sino Biological launches 2026-2027 Northern Hemisphere influenza vaccine strain antigens
Centivax Inc doses first healthy volunteers in Centi-Flu 01 Phase 1A clinical trial
Delonix Bioworks gets IND clearance for DX-104 in China
Valneva and Instituto Butantan launch pilot chikungunya vaccination campaign in Brazil
European Commission approves GSK's Arexvy for adults aged 18 and over
PhotonPharma adds Dr. William Warren to board
GSK wins European Commission approval for Shingrix prefilled syringe
Sanofi agrees USD2.2bn acquisition of Dynavax to strengthen adult vaccine portfolio
ECO Animal Health Group secures EU approval for ECOVAXXIN MS